Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers - The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854-8020, USA.
Bioorg Med Chem. 2013 Aug 1;21(15):4511-20. doi: 10.1016/j.bmc.2013.05.033. Epub 2013 May 30.
A series of macrocyclic biphenyl tetraoxazoles was synthesized. The latter stages of the synthetic approach allowed for the addition of varied N-protected α-amino acids, which were subsequently deprotected and condensed to provide the desired macrocycles. Improved yields could be realized in the macrocyclization step of their synthesis relative to other macrocyclic G-quadruplex stabilizers. These 24-membered macrocycles were evaluated for their ability to stabilize G-quadruplex DNA and for their relative cytotoxicity against human tumor cells. These biphenyl tetraoxazoles were not strong ligands for G-quadruplex DNA relative to other macrocyclic polyoxazoles. This reduced stabilizing potential did correlate with their comparatively lower cytotoxic activity as observed in the human tumor cell lines, RPMI 8402 and KB3-1. These studies provide useful insights into the conformational requirements for the development of selective and more potent G-quadruplex ligands.
合成了一系列大环联苯四恶唑。该合成方法的后阶段允许添加各种 N-保护的α-氨基酸,然后将其脱保护并缩合以提供所需的大环。与其他大环 G-四链体稳定剂相比,它们的合成中环化步骤的产率可以提高。这些 24 元大环被评估其稳定 G-四链体 DNA 的能力及其对人肿瘤细胞的相对细胞毒性。与其他大环聚恶唑相比,这些联苯四恶唑相对不是 G-四链体 DNA 的强配体。这种稳定潜力的降低与在人肿瘤细胞系 RPMI 8402 和 KB3-1 中观察到的相对较低的细胞毒性活性相关。这些研究为开发选择性和更有效的 G-四链体配体提供了有用的见解。